Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 02/15/22 → 05/23/24 |
Funding
- Genentech Incorporated: $11,250.00
Labcorp Drug Dev: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of PRM-151 in Patients with Idiopathic Pulmonary Fibrosis
- Desai, Alpa (PI)
- Strachan, Paul (PI)
Project: Research